When and where is JIHE 2026 held?

JIHE 2026 will be held on November 13-14, 2026 at House of OMOTESANDO (5-34-8 Jingumae, Shibuya-ku, Tokyo).

Is there an admission fee?

General admission is free with pre-registration. Some programs, such as the networking party, may require additional fees.

How can I become an exhibitor?

You can apply to exhibit through the contact form on our official website. We offer various booth and sponsorship packages to suit your needs.

How can I apply to speak at the conference?

If you'd like to speak at CannaCon, please submit your application through our contact form and select 'Speaker.' We welcome presentations from international experts in the hemp and cannabis industry.

What kind of programs does JIHE offer?

JIHE features exhibitions (CBD Journey & HEMP Journey), conferences (CannaCon), networking events, and hands-on workshops — offering a comprehensive hemp industry experience.

Can international visitors attend?

Yes, JIHE is an international expo. We welcome visitors, exhibitors, and speakers from around the world. Sessions by international speakers cross the language barrier with AI interpretation.

Does JIHE have a track record of past events?

Yes, JIHE evolved from the integration of CBD Journey and CannaCon events. You can view past attendance figures and exhibitor details on our Past Event Reports page.

SPEAKERS

Speakers

The speakers at our CannaCon conference. Select a name to see their profile and sessions.

Speaker and participating company information will be added progressively. As of 2 October 2026.

Official sponsors

Speakers from our official sponsors.

DAY 1 · Fri 13 Nov

What Japan's hemp industry needs to grow: cultivation, seeds, breeding and regulation

Japanese & English, AI subtitlesMC: Naoko MikiSee in the programme

Will cannabis-derived medicines ever be available in Japan?

JapaneseMC: Yuji MasatakaSee in the programme

Medical cannabis and cancer care

Japanese & English, AI subtitlesMC: Naoko MikiSee in the programme

CBN today and the inconvenient truth

JapaneseMC: Yuji MasatakaSee in the programme

Quality control and traceability: connecting every step from cultivation to the consumer

Japanese & English, AI subtitlesMC: Naoko MikiSee in the programme

DAY 2 · Sat 14 Nov

Latest trends in the CBD and cannabis industry overseas and their impact on the Japanese market

EnglishMC: Naoko MikiSee in the programme

Go-to-market strategies for Japan's hemp industry: what should we make to reach consumers?

JapaneseMC: Yuji MasatakaSee in the programme

Cannabis in integrative medicine: cannabis as a medicinal herb and the potential of terpenes

JapaneseMC: Naoko MikiSee in the programme

Session to be announced

Session details and speaking times will be announced once confirmed.

Speakers and sessions are subject to change. Updates will be posted on this page.

SPEAKERS

Speakers

The speakers at our CannaCon conference. Select a name to see their profile and sessions.

Speaker and participating company information will be added progressively. As of 2 October 2026.

Official sponsors

Speakers from our official sponsors.

DAY 1 · Fri 13 Nov

What Japan's hemp industry needs to grow: cultivation, seeds, breeding and regulation

Japanese & English, AI subtitlesMC: Naoko MikiSee in the programme

Will cannabis-derived medicines ever be available in Japan?

JapaneseMC: Yuji MasatakaSee in the programme

Medical cannabis and cancer care

Japanese & English, AI subtitlesMC: Naoko MikiSee in the programme

CBN today and the inconvenient truth

JapaneseMC: Yuji MasatakaSee in the programme

Quality control and traceability: connecting every step from cultivation to the consumer

Japanese & English, AI subtitlesMC: Naoko MikiSee in the programme

DAY 2 · Sat 14 Nov

Latest trends in the CBD and cannabis industry overseas and their impact on the Japanese market

EnglishMC: Naoko MikiSee in the programme

Go-to-market strategies for Japan's hemp industry: what should we make to reach consumers?

JapaneseMC: Yuji MasatakaSee in the programme

Cannabis in integrative medicine: cannabis as a medicinal herb and the potential of terpenes

JapaneseMC: Naoko MikiSee in the programme

Session to be announced

Session details and speaking times will be announced once confirmed.

Speakers and sessions are subject to change. Updates will be posted on this page.

Speakers

Official sponsors

Stephan MoreelsManaging Director, Control Union (Thailand) Co. LtdSpeaking on: Fri 13 Nov

Kohei YamadaFounder & CEO, KISEKI GROUP CORP.Speaking on: Fri 13 Nov

Mary Szomjassy BrownCo-Founder & COO, TrueImports ／ Coast2Coast Consulting ／ Chief Clinical Officer, Canvas TherapeuticsSpeaking on: Fri 13 Nov

Michael HadjisavasHead of Life Sciences and Healthcare, p-Chip CorporationSpeaking on: Fri 13 Nov

DAY 1 · Fri 13 Nov

What Japan's hemp industry needs to grow: cultivation, seeds, breeding and regulation

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator

Anar ArturFounder, CBD Mongolia LLC

THTakeshi HarigayaDirector, Kanna Research Institute

Aya AmmiChair, HEMP HUB ／ Hemp Industry Coordinator, Japan Hemp Industrial Development Organization (HIDO)

Elena YanevaCEO & co-founder, Hempstatic

Dr. Patrick ChinFounder & CEO, Clairvoyant Lab

Stephan MoreelsManaging Director, Control Union (Thailand) Co. Ltd

Paul BenhaimFounder, Cannabis Psychedelics ／ Chairman, The Hemp Plastic Company ／ President, The Hemp Consultant

Will cannabis-derived medicines ever be available in Japan?

MCYuji MasatakaRepresentative Director, GREEN ZONE JAPAN ／ Vice Chair, Japanese Clinical Association of Cannabinoids (JCAC)

Ichiro TakumiChair, Japanese Clinical Association of Cannabinoids (JCAC) ／ Professor of Neurosurgery and Director of the Epilepsy Center, St. Marianna University School of Medicine

Kohei YamadaFounder & CEO, KISEKI GROUP CORP.

Medical cannabis and cancer care

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator

Kohei YamadaFounder & CEO, KISEKI GROUP CORP.

Mary Szomjassy BrownCo-Founder & COO, TrueImports ／ Coast2Coast Consulting ／ Chief Clinical Officer, Canvas Therapeutics

Asao OgawaChief, Department of Psycho-Oncology, National Cancer Center Hospital East ／ Chief, Division of Psycho-Oncology, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center

CBN today and the inconvenient truth

MCYuji MasatakaRepresentative Director, GREEN ZONE JAPAN ／ Vice Chair, Japanese Clinical Association of Cannabinoids (JCAC)

Ichiro TakumiChair, Japanese Clinical Association of Cannabinoids (JCAC) ／ Professor of Neurosurgery and Director of the Epilepsy Center, St. Marianna University School of Medicine

Kosuke HikitaPhysician, Medical Green Clinic

Yuuka OsadaPhysician, Den-en-chofu Osada Orthopedic Clinic (Comprehensive Preventive Medicine)

菊池 星来Medical CBN ／ Japanese Clinical Association of Cannabinoids

Quality control and traceability: connecting every step from cultivation to the consumer

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator

Kohei YamadaFounder & CEO, KISEKI GROUP CORP.

Mary Szomjassy BrownCo-Founder & COO, TrueImports ／ Coast2Coast Consulting ／ Chief Clinical Officer, Canvas Therapeutics

Michael HadjisavasHead of Life Sciences and Healthcare, p-Chip Corporation

Stephan MoreelsManaging Director, Control Union (Thailand) Co. Ltd

Kaito AmanoOperations Manager, KCA Labs Japan LLC

DAY 2 · Sat 14 Nov

Latest trends in the CBD and cannabis industry overseas and their impact on the Japanese market

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator

Dr. Mark G. DarkoPresident/CEO, Chamber of Cannabis Industry-Ghana ／ Global President, Africa International Chamber of Commerce and Industry

Laura RamosCo-founder & Editor-in-Chief, CannaReporter

Morris BeegleFounder, Industrial Hemp International ／ RootSource Media / Print On Hemp / Bio-Smart Group

Sharon Deidre Leyson (Dydy)Secretary General, Asia International Hemp Federation (AIHF)

Go-to-market strategies for Japan's hemp industry: what should we make to reach consumers?

MCYuji MasatakaRepresentative Director, GREEN ZONE JAPAN ／ Vice Chair, Japanese Clinical Association of Cannabinoids (JCAC)

Takamasa KitamuraASAFUKU Co., Ltd.

Shohei OkudaRepresentative Director, GUE TRADING Inc. ／ Yashu Asazumi Lab

Eisuke MurogaPresident & Representative Director, Yawataya Isogoro Co., Ltd.

Takehiro DaitohHead of Business, weavearth Linen and Hemp

Cannabis in integrative medicine: cannabis as a medicinal herb and the potential of terpenes

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator

Shinichiro HayashiRepresentative, Green Flask Co., Ltd. ／ Director, Green Flask Research Institute

Kazushige MatsumotoEditorial & Operations Support, HempTODAY JAPAN ／ Editorial & Operations Support, HSI JAPAN

Session to be announced

Rehan MehtaCEO, Thai Stick Co., Ltd.

Imran RashidDevelopment & Implementation, Senti Solutions ／ Evolved Extraction Solutions ／ Founder, Extractwise

Speakers

Official sponsors

Stephan MoreelsManaging Director, Control Union (Thailand) Co. LtdSpeaking on: Fri 13 Nov

Kohei YamadaFounder & CEO, KISEKI GROUP CORP.Speaking on: Fri 13 Nov

Mary Szomjassy BrownCo-Founder & COO, TrueImports ／ Coast2Coast Consulting ／ Chief Clinical Officer, Canvas TherapeuticsSpeaking on: Fri 13 Nov

Michael HadjisavasHead of Life Sciences and Healthcare, p-Chip CorporationSpeaking on: Fri 13 Nov

DAY 1 · Fri 13 Nov

What Japan's hemp industry needs to grow: cultivation, seeds, breeding and regulation

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator

Anar ArturFounder, CBD Mongolia LLC

THTakeshi HarigayaDirector, Kanna Research Institute

Aya AmmiChair, HEMP HUB ／ Hemp Industry Coordinator, Japan Hemp Industrial Development Organization (HIDO)

Elena YanevaCEO & co-founder, Hempstatic

Dr. Patrick ChinFounder & CEO, Clairvoyant Lab

Stephan MoreelsManaging Director, Control Union (Thailand) Co. Ltd

Paul BenhaimFounder, Cannabis Psychedelics ／ Chairman, The Hemp Plastic Company ／ President, The Hemp Consultant

Will cannabis-derived medicines ever be available in Japan?

MCYuji MasatakaRepresentative Director, GREEN ZONE JAPAN ／ Vice Chair, Japanese Clinical Association of Cannabinoids (JCAC)

Ichiro TakumiChair, Japanese Clinical Association of Cannabinoids (JCAC) ／ Professor of Neurosurgery and Director of the Epilepsy Center, St. Marianna University School of Medicine

Kohei YamadaFounder & CEO, KISEKI GROUP CORP.

Medical cannabis and cancer care

MCNaoko MikiDirector, GREEN ZONE JAPAN ／ Translator